Sailong Pharmaceutical Group Co.,Ltd.

002898

CNE1000032S5

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 04/06/2024 am IST			5-day change	1st Jan Change
9.18 ^CNY	-2.24%		-5.07%	-34.29%

19/04	Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
08/04	Sailong Pharmaceutical Group Co.,Ltd. Approves Board Elections	CI

Zhuhai Sailong Pharmaceutical Co.,Ltd. Approves Cash Dividend for 2019

May 22, 2020 at 01:06 am IST

Zhuhai Sailong Pharmaceutical Co.,Ltd. approved cash dividend/10 shares (tax included) of CNY 0.30000000 for 2019 at the Annual General Meeting held on 20 May 2020.

Latest news about Sailong Pharmaceutical Group Co.,Ltd.

Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	19/04	CI
Sailong Pharmaceutical Group Co.,Ltd. Approves Board Elections	09/04	CI
Sailong Pharma's Unit Gets Nod to Market Pregabalin	08/03	MT
Sailong Pharma Gets Registration Certificate for Pregabalin Capsules	04/03	MT
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25/23/25	CI
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/23/24	CI
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	19/23/19	CI
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	19/23/19	CI
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	28/22/28	CI
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/22/25	CI
Sailong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	26/22/26	CI
Sailong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	26/21/26	CI
Zhuhai Sailong Pharmaceutical : Sailong Pharmaceutical Adopts New Name	07/21/07	MT
Zhuhai Sailong Pharmaceutical Co.,Ltd. has Changed its Name to Sailong Pharmaceutical Group Co., Ltd	03/21/03	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	25/21/25	CI
Wu Gulin signed share transfer agreement to acquire Hunan Shenglong Real Estate Co., Ltd. from Zhuhai Sailong Pharmaceutical Co.,Ltd. for CNY 10.2 million.	18/21/18	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Proposes No Final Dividend for 2020	01/21/01	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Announces Earnings Results for the First Quarter Ended March 31, 2021	29/21/29	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	29/21/29	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	27/20/27	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	10/20/10	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Announces Implementation of A Share Dividend for the Year 2019, Payable on 16 July 2020	09/20/09	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Approves Cash Dividend for 2019	22/20/22	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Announces Final Cash Dividend for 2019	30/20/30	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	29/20/29	CI

Chart Sailong Pharmaceutical Group Co.,Ltd.

Duration

Period

Chart Sailong Pharmaceutical Group Co.,Ltd.

More charts

Sailong Pharmaceutical Group Co Ltd, formerly Zhuhai Sailong Pharmaceutical Co Ltd, is a China-based company principally engaged in the research and development, production and sales of pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and preparations, as well as providing technical services. The Companyâs main products include monosialin tetrahexose ganglioside sodium injections, brain protein hydrolyzate for injections, clindamycin phosphate for injections, pantoprazole sodium for injections and milrinon injections, among others. Through its subsidiaries, the Company is also engaged in the sales of scraps, provision of technical services and sales promotion. The Company mainly conducts its businesses with domestic market.

Sector

Pharmaceuticals

Calendar

23/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
SAILONG PHARMACEUTICAL GROUP CO.,LTD.	-34.29%	223M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+18.09%	41.07B
OTSUKA HOLDINGS CO., LTD.	+24.16%	22.65B
SANDOZ GROUP AG	+13.90%	15.02B
CIPLA LIMITED	+20.11%	14.14B
ZYDUS LIFESCIENCES LIMITED	+52.15%	12.09B
ONO PHARMACEUTICAL CO., LTD.	-10.97%	6.91B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+15.28%	5.59B